nderstanding overweight and obesity: The end of average

Conditions: Obesitas, overgewicht
corpulence
adiposity

Registration Number: NL-OMON53868

Lead Sponsor: niversiteit Maastricht

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 600

Inclusion Criteria

1. Is informed and has been given a minimum of 7 days to consider participation
and has given informed consent in writing; 2. Is male or female and in the age
range between 18 and 65 years (inclusive); 3. Has a body mass index (BMI) in
one of the following ranges - Healthy weight: >=18.5 and <=25.0 kg/m2; -
Overweight: >25.0 and <=30.0 kg/m2; - Obese: >30.0 kg/m2 4. Is a fluent Dutch
speaker. 5. Has been weight stable (±3 kg) for the past three months.

Exclusion Criteria

1. Female participant who is pregnant;
2. Is currently in specialized treatment for overweight/obesity;
3. Is currently in specialized treatment for a mental disorder;
4. Has had gastric surgery;
5. Is taking medication for chronic conditions such as diabetes, pulmonary
disease, and heart and vascular disease that interfere with the measurements of
the current study.
6. Is not capable of taking part in all measurements;
7. Is physically disabled.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>At baseline, a comprehensive set of variables will be assessed, all of which<br /><br>have been associated with overweight and obesity in previous empirical studies.<br /><br>These include biomedical variables (e.g., ghrelin and leptin), psychological<br /><br>variables (e.g., depressive symptoms), person characteristics (e.g., age),<br /><br>environmental variables (e.g., neighbourhood safety) and behavioural variables<br /><br>(e.g., usual eating habits). It In addition, we will collect time-series data<br /><br>on (un)healthy eating and physical (in)activity, and predictors of these<br /><br>behaviours (e.g., emotions) in daily life, both at baseline and after<br /><br>intervention. </p><br>

Secondary Outcome Measures